We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Rustam Al-Shahi
Salman
rustam.al-shahi@ed.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Cerebrovascular diseases
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background: Clinical trials have not found a treatment that works specifically for stroke caused by bleeding in the brain, known as intracerebral haemorrhage (ICH for short). Most clinical trials have studied one treatment at a time and included only 1 in 10 people with ICH. That’s why each clinical trial recruited only 77 participants on average. A PLatform trial for INTracerebral Haemorrhage (PLINTH) will change this by investigating several treatments and giving everyone with ICH an opportunity to take part.
Aim: We intend PLINTH to be large, inclusive, efficient and assess several treatments for ICH. First, we must do a feasibility study to work out whether PLINTH can succeed.
Methods: We will find people recently diagnosed with ICH in Lothian and Lanarkshire and invite them to take part in our feasibility study. We will provide them with personalised information using Tailored Talks. We will find out if PLINTH is acceptable to people with ICH, carers, and doctors. We will use data that are collected routinely to follow participants’ progress. Characteristics and outcomes of participants will help design PLINTH.
Patient & public involvement: We asked ICH survivors about PLINTH: 92% strongly agreed that working out how to do a platform study to find treatments for ICH is a priority. An ICH survivor is in our team.
Dissemination: We will produce easy access reports and share them with people with ICH, carers, healthcare professionals, and the public in their preferred format (printed, email, social media, and on our website www.RUSH.ed.ac.uk).
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
• People aged <18 years at the time of ICH diagnosis • Exclusively extra-axial intracranial haemorrhage or ICH definitely attributable to a macrovascular cause (e.g. aneurysm, arteriovenous malformation, cavernoma, cerebral venous sinus thrombosis), tumour, trauma or haemorrhagic transformation of an ischaemic stroke • Responsible clinician deems it inappropriate to approach the patient or their nearest relative (e.g. death appears imminent) • Mental incapacity and no nearest relative, welfare attorney or welfare guardian available at the time of approach • Patient died before approached for consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Rustam Al-Shahi
Salman
rustam.al-shahi@ed.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Edinburgh and funded by Scottish Government Chief Scientist Office (CSO) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 58862
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
